These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3054858)

  • 1. Effects of the benzazepine SCH 23390 on prolactin release from isolated pituitary.
    Navarra P; del Carmine R; Ragazzoni E; Vacca M; Preziosi P
    Pharmacol Toxicol; 1988 Aug; 63(2):135-6. PubMed ID: 3054858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretion.
    Rovescalli AC; Brunello N; Monopoli A; Ongini E; Racagni G
    Eur J Pharmacol; 1987 Mar; 135(2):129-36. PubMed ID: 3556197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
    Schoors DF; Vauquelin GP; De Vos H; Smets G; Velkeniers B; Vanhaelst L; Dupont AG
    Br J Pharmacol; 1991 Aug; 103(4):1928-34. PubMed ID: 1833020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919.
    Domae M; Yamada K; Hanabusa Y; Matsumoto S; Furukawa T
    Eur J Pharmacol; 1990 Apr; 179(1-2):75-82. PubMed ID: 2142088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary.
    Cocchi D; Ingrassia S; Rusconi L; Villa I; Müller EE
    Eur J Pharmacol; 1987 Oct; 142(3):425-9. PubMed ID: 2962879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D; Di Paolo T
    Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological concentrations of dopamine decrease adenosine 3',5'-monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs: evidence for a causal relationship to inhibition of prolactin release.
    Swennen L; Denef C
    Endocrinology; 1982 Aug; 111(2):398-405. PubMed ID: 6284477
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats.
    Tanimoto K; Tamminga CA; Chase TN
    Eur J Pharmacol; 1987 Dec; 144(2):147-51. PubMed ID: 3325296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cells.
    Login IS; Trugman JM
    Neuropharmacology; 1989 Jun; 28(6):647-50. PubMed ID: 2547181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of endothelin-1 and endothelin-3 on prolactin release: possible involvement of endogenous endothelin isopeptides in the rat anterior pituitary.
    Domae M; Yamada K; Hanabusa Y; Furukawa T
    Life Sci; 1992; 50(10):715-22. PubMed ID: 1738298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of increased prolactin secretion by sulpiride.
    MacLeod RM; Robyn C
    J Endocrinol; 1977 Mar; 72(3):273-7. PubMed ID: 853259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulatory effects of quinpirole hydrochloride, D2-dopamine receptor agonist, at low concentrations on prolactin release in female rats in vitro.
    Tagawa R; Takahara J; Sato M; Niimi M; Murao K; Ishida T
    Life Sci; 1992; 51(10):727-32. PubMed ID: 1355255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and behavioral effects of D1 dopamine antagonists.
    Barnett A; Iorio LC; McQuade R; Chipkin RE
    Adv Exp Med Biol; 1988; 235():137-44. PubMed ID: 2976247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D1 receptor analogues act centrally to stimulate prolactin secretion in ewes.
    Curlewis JD; Clarke IJ; McNeilly AS
    J Endocrinol; 1993 Jun; 137(3):457-64. PubMed ID: 8371076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-2 dopamine receptor activation reduces free [3H]arachidonate release induced by hypophysiotropic peptides in anterior pituitary cells.
    Canonico PL
    Endocrinology; 1989 Sep; 125(3):1180-6. PubMed ID: 2527149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
    Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro evidence for the autoregulation of prolactin secretion at the level of the pituitary gland in the rat.
    Bentley AM; Wallis M
    J Endocrinol; 1987 Oct; 115(1):13-8. PubMed ID: 3668441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
    Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
    Neurosci Lett; 1988 Mar; 85(3):363-9. PubMed ID: 3362424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.